Below you'll find a list of trials that are currently taking place in the UK. We update this list regularly, so it's worth coming back if you don't immediately find a trial that is appropiate for you.

Disclaimer: Trials listed on our site are not endorsed by Sarcoma UK. The decision about whether to join a trial is your own. We offer signposting to appropriate trials, however we are unable to say whether you will ultimately be eligible to take part. Sarcoma UK is unable to refer you directly to a trial. Please discuss trials with your clinical team.  
 
The safety and validity of each trial is the responsibility of its sponsor (the company/body that funds it) and its investigators (the clinicians and researchers running the trial) and not of Sarcoma UK. The information we provide is limited, and does not include all details relevant to participation in a trial. We aim to provide accurate and up to date trial information, however we rely on sources outside of Sarcoma UK to do this. 

Sarcoma Type: 
Gastrointestinal stromal tumours (GIST)

A trial looking at using imatinib after surgery to treat GIST that has a high risk of recurrence.

Sarcoma Type: 
Synovial sarcoma

This trial looks to find out if the drug ADP-A2M4 is safe and how well it works in attacking synovial sarcoma or Myxoid/Round Cell Liposarcoma cancer cells.

Sarcoma Type: 
Ewing's sarcoma

A trial looking at chemotherapy to treat Ewing's sarcoma.

Sarcoma Type: 
Osteosarcoma

This study compares the effectiveness and safety of the drug Lenvatinib with Ifosfamide and Etoposide, compared to Ifosfamide and Etoposide alone.

Sarcoma Type: 
Synovial sarcoma

This study assesses the safety and effectiveness of GSK3377794 in treating synovial sarcoma.

Sarcoma Type: 
Osteosarcoma

The purpose of this project is to collect high quality clinical data about patients of all ages with osteosarcoma.

A trial looking at cabozantinib after chemotherapy, for sarcoma of the womb that has spread or can’t be treated with surgery.

Sarcoma Type: 
Leiomyosarcoma

This study assesses the safety and side effects of Pembrolizumab in combination with gemcitabine chemotherapy, for patients with newly diagnosed metastatic or inoperable leiomyosarcoma and undifferentiated pleomorphic sarcoma.

Sarcoma Type: 
Rhabdomyosarcoma

This study will assess several treatment therapies, looking at survival and long term side effects of treatment in children, teenagers and adults with newly diagnosed or recurrent rhabdomyosarcoma.

This study looks at how patients respond to the drug tazemetostat. 

Pages